Amgen Inc. has issued four new series of senior unsecured notes, raising net proceeds of approximately $3.96 billion. These notes, maturing between 2031 and 2056, will pay semi-annual interest and rank equally with other senior unsecured debt. The offering was conducted under an existing shelf registration, expanding Amgen’s fixed-rate funding.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Amgen (NASDAQ: AMGN) sells four new series of senior notes
Amgen Inc. has issued four new series of senior unsecured notes, raising net proceeds of approximately $3.96 billion. These notes, maturing between 2031 and 2056, will pay semi-annual interest and rank equally with other senior unsecured debt. The offering was conducted under an existing shelf registration, expanding Amgen’s fixed-rate funding.